UNICREDIT BANK/CALL/ABBVIE/200/0.1/18.06.25 Share Price

Warrant

DE000HC7N0A3

Market Closed - BOERSE MUENCHEN 01:12:08 01/06/2024 am IST
0.35 EUR +20.69% Intraday chart for UNICREDIT BANK/CALL/ABBVIE/200/0.1/18.06.25
1 month-27.08%
3 months-63.54%
Date Price Change
31/24/31 0.35 +20.69%
30/24/30 0.29 +3.57%
29/24/29 0.28 +3.70%
28/24/28 0.27 -12.90%
27/24/27 0.31 -.--%

Real-time BOERSE MUENCHEN

Last update May 01, 2024 at 01:12 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC7N0A
ISINDE000HC7N0A3
Date issued 23/06/2023
Strike 200 $
Maturity 18/06/2025 (381 Days)
Parity 10 : 1
Emission price 0.39
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.18
Lowest since issue 0.2
Delta0.21x
Omega 8.387
Premium27.24x
Gearing39.42x
Moneyness 0.8019
Difference Strike 38.76 $
Difference Strike %+19.38%
Spread 0.01
Spread %2.63%
Theoretical value 0.3950
Implied Volatility 22.62 %
Total Loss Probability 83.56 %
Intrinsic value 0.000000
Present value 0.3950
Break even 204.29 €
Theta-0.01x
Vega0.04x
Rho0.03x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
161.2 USD
Average target price
182.1 USD
Spread / Average Target
+12.95%
Consensus